These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17432277)

  • 1. The influence of the extrusion die on pellet characteristics.
    Rabisková M; Weingartová D; Häring A
    Ceska Slov Farm; 2007 Jan; 56(1):17-20. PubMed ID: 17432277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bi-layered self-emulsifying pellets prepared by co-extrusion and spheronization: influence of formulation variables and preliminary study on the in vivo absorption.
    Iosio T; Voinovich D; Grassi M; Pinto JF; Perissutti B; Zacchigna M; Quintavalle U; Serdoz F
    Eur J Pharm Biopharm; 2008 Jun; 69(2):686-97. PubMed ID: 18191390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in characteristics of pellets prepared by different pelletization methods.
    Häring A; Vetchý D; Janovská L; Krejcová K; Rabisková M
    Drug Dev Ind Pharm; 2008 Mar; 34(3):289-96. PubMed ID: 18363144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Masking of unpleasant gustatory sensation by cross-linking of dehydrated paracetamol alginate pellets produced by extrusion-spheronization.
    Kulkarni RB; Amin PD
    Drug Dev Ind Pharm; 2008 Feb; 34(2):199-205. PubMed ID: 18302039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immediate release of poorly soluble drugs from starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; Remon JP; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2007 Nov; 67(3):715-24. PubMed ID: 17537625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Starch-dextrin mixtures as base excipients for extrusion-spheronization pellets.
    Almeida Prieto S; Blanco Méndez J; Otero Espinar FJ
    Eur J Pharm Biopharm; 2005 Apr; 59(3):511-21. PubMed ID: 15760732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigations on the influence of the type of extruder for pelletization by extrusion-spheronization. II. Sphere characteristics.
    Thoma K; Ziegler I
    Drug Dev Ind Pharm; 1998 May; 24(5):413-22. PubMed ID: 9876603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug solubility effects on predicting optimum conditions for extrusion and spheronization of pellets.
    Hileman GA; Upadrashta SM; Neau SH
    Pharm Dev Technol; 1997 Feb; 2(1):43-52. PubMed ID: 9552430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of the speed of spheronization on the physical properties and dissolution availability of theophylline minigranules prepared by extrusion-spheronization].
    Rahman L; Gaudy D; Bataille B; Jacob M; Puech A
    J Pharm Belg; 1991; 46(6):389-95. PubMed ID: 1783973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Extrusion/spheronization: an important method for the production of the pellet dosage form].
    Häring A; Rabisková M
    Ceska Slov Farm; 2007 Jan; 56(1):11-6. PubMed ID: 17432276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and evaluation of omeprazole pellets fabricated by sieving-spheronization and extrusion - spheronization process.
    Karim S; Baie SH; Hay YK; Bukhari NI
    Pak J Pharm Sci; 2014 May; 27(3):425-38. PubMed ID: 24811797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alginate-based pellets prepared by extrusion/spheronization: a preliminary study on the effect of additive in granulating liquid.
    Sriamornsak P; Nunthanid J; Luangtana-anan M; Puttipipatkhachorn S
    Eur J Pharm Biopharm; 2007 Aug; 67(1):227-35. PubMed ID: 17276664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of formulation and excipient variables on the pellet properties prepared by extrusion spheronization.
    Sinha VR; Agrawal MK; Kumria R
    Curr Drug Deliv; 2005 Jan; 2(1):1-8. PubMed ID: 16305403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Parameters for the formulation of physical-technical characteristics of granules of theophylline obtained by extrusion-spheronization].
    Bataille B; Rahman L; Jacob M
    Pharm Acta Helv; 1991; 66(8):233-6. PubMed ID: 1758901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of extrusion aids for successful production of Kollidon
    Loka NC; Saripella KK; Pinto CA; Neau SH
    Drug Dev Ind Pharm; 2018 Apr; 44(4):632-642. PubMed ID: 29183166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the drying technique on theophylline pellets prepared by extrusion-spheronization.
    Pérez J; Rabisková M
    Int J Pharm; 2002 Aug; 242(1-2):349-51. PubMed ID: 12176277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation on drug dissolution and particle characteristics of pellets related to manufacturing process variables of high-shear granulation.
    Dévay A; Mayer K; Pál S; Antal I
    J Biochem Biophys Methods; 2006 Nov; 69(1-2):197-205. PubMed ID: 16650480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of drug solubility and particle size on the pellet formulation in a rotoprocessor.
    Krejcová K; Rabisková M; Vetchý D; Polásek E; Tomásek V; Prokopová A
    Drug Dev Ind Pharm; 2006 Jun; 32(5):585-93. PubMed ID: 16720413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of plate design on the properties of pellets produced by extrusion and spheronization.
    Michie H; Podczeck F; Newton JM
    Int J Pharm; 2012 Sep; 434(1-2):175-82. PubMed ID: 22659150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.